What is the role of radiotherapy in malignant pleural mesothelioma?

Oncologist

Volumn 16, Issue 3, 2011, Pages 359-365

  Price, Allan ^a  

^a Edinburgh Cancer Centre   (United Kingdom)

Author keywords

Mesothelioma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IODINE 125; PEMETREXED; PHOSPHORUS 32;

ARTICLE; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG EMBOLISM; LUNG RESECTION; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL (TOPIC); PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPY EFFECT;

CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; HUMANS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES; RADIATION ONCOLOGY;

EID: 79953016245     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0185     Document Type: Article

References (51)

1. Gordon W Jr, Antman KH, Greenberger JS et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982;8:19-25.
2. Hilaris BS, Nori D, Kwong E et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1984;10:325-331.
3. Maasilta P. Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys 1991;20:433-438.
4. Holsti LR, Pyrhönen S, Kajanti M et al. Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment. Acta Oncol 1997;36:397-405.
5. Sugarbaker DJ, Garcia JP, Richards WG et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Re- sults in 120 consecutive patients. Ann Surg 1996;224:288-294; discussion 294-296.
6. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002;22:298-305.
7. Rusch VW, Rosenzweig K, Venkatraman E et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-795.
8. Baldini EH, Recht A, Strauss GM et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997;63: 334-338.
9. Allen AM, Den R, Wong JS et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys 2007;68:1366-1374.
10. Forster KM, Smythe WR, Starkschall G et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 2003;55:606-616.
11. Ahamad A, Stevens CW, Smythe WR et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 2003;9:476-484.
12. Münter MW, Nill S, Thilmann C et al. Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results. Strahlenther Onkol 2003; 179:535-541.
13. Rice DC, Stevens CW, Correa AM et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685-1692; discussion 1692-1693.
14. Rice DC, Smythe WR, Liao Z et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2007;69:350-357.
15. Allen AM, Czerminska M, Jänne PA et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;65:640-645.
16. Buduhan G, Menon S, Aye R et al. Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 2009;88:870-875; discussion 876.
17. Kristensen CA, Nøttrup TJ, Berthelsen AK et al. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma. Radiother Oncol 2009;92:96-99.
18. Miles EF, Larrier NA, Kelsey CR et al. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys 2008;71:1143-1150.
19. Chan MF, Chui CS, Song Y et al. A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons. Radiother Oncol 2006;79:218-223.
20. Javedan K, Stevens CW, Forster K. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy. J Appl Clin Med Phys 2008;9:2799.
21. Hill-Kayser CE, Avery S, Mesina CF et al. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques. J Thorac Oncol 2009; 4:1431-1437.
22. Krayenbuehl J, Oertel S, Davis JB et al. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Int J Radiat Oncol Biol Phys 2007;69:1593-1599.
23. Jang SY, Liu HH, Mohan R. Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:1537-1546.
24. Allen AM, Schofield D, Hacker F et al. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys 2007;69:1587-1592.
25. Flores RM, Krug LM, Rosenzweig KE et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 2006;1:289-295.
26. Pagan V, Ceron L, Paccagnella A et al. 5-year prospective results of trimodality treatment for malignant pleural mesothelioma. J Cardiovasc Surg (Torino) 2006;47:595-601.
27. Rea F, Marulli G, Bortolotti L et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 2007; 57:89-95.
28. Weder W, Stahel RA, Bernhard J et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-1202.
29. Batirel HF, Metintas M, Caglar HB et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 2008;3:499-504.
30. Van Schil P, Baas P, Gaafar R et al. Phase II feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for cT3N1M0 or less malignant pleural mesothelioma (MPM) (EORTC 08031). J Clin Oncol 2009(15 suppl): 7509.
31. Krug LM, Pass HI, Rusch VW et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27: 3007-3013.
32. Treasure T, Waller D, Tan C et al. The mesothelioma and radical surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009;4:1254-1258.
33. Gupta V, Mychalczak B, Krug L et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005;63:1045-1052.
34. Lee TT, Everett DL, Shu HK et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124:1183-1189.
35. Lucchi M, Chella A, Melfi F et al. Four-modality therapy in malignant pleural mesothelioma: a phase II study. J Thorac Oncol 2007;2:237-242.
36. Luckraz H, Rahman M, Patel N et al. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg 2010;37:552-556.
37. Low EM, Khoury GG, Matthews AW et al. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol (R Coll Radiol) 1995;7:317-318.
38. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma.Arandomized trial of local radiotherapy. Chest 1995;108:754-758.
39. Bydder S, Phillips M, Joseph DJ et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004;91:9-10.
40. O'Rourke N, Garcia JC, Paul J et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007;84:18-22.
41. Metintas M, Ak G, Parspour S et al. Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma. Lung Cancer 2008;61: 255-261.
42. De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey. Radiother Oncol 2003;68:299-302.
43. Lee C, Bayman N, Swindell R et al. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer 2009;66:150-156.
44. West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med 2006;100:1037-1040.
45. Di Salvo M, Gambaro G, Pagella S et al. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma. Acta Oncol 2008;47:1094-1098.
46. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13:4-9.
47. Davis SR, Tan L, Ball DL. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol 1994;38:212-214.
48. Bissett D, Macbeth FR, Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol) 1991;3:315-317.
49. Lindén CJ, Mercke C, Albrechtsson U et al. Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study. Eur Respir J 1996;9: 2565-2572.
50. de Graaf-Strukowska L, van der Zee J, van Putten W et al. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura- a single-institution experience with 189 patients. Int J Radiat Oncol Biol Phys 1999;43:511-516.
51. Ung YC, Yu E, Falkson C et al. The role of radiation therapy in malignant pleural mesothelioma: a systematic review. Radiother Oncol 2006; 80:13-18.